HIV and SIV gp120 binding does not predict coreceptor function

Virology

Volumn 259, Issue 2, 1999, Pages 267-273

  Baik, Sarah S W ^a   Doms, Robert W ^a   Doranz, Benjamin J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR5; GLYCOPROTEIN GP 120; VIRUS GLYCOPROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN BINDING; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS INFECTIVITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033526795     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9779     Document Type: Article

References (22)

1. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens. Science. 280:1998;1884-1888.
2. Doms R. W., Moore J. P. HIV coreceptor use: A molecular window into viral tropism. Korber B., Foley B., Leitner T., Myers G., Hahn B., McCutchan F., Mellors J., Kuiken C. Theoretical Biology and Biophysics, 1998;1-12 Los Alamos National Laboratory, Los Alamos.
3. Berson J. F., Doms R. W. Structure-function studies of the HIV-1 coreceptors. Semin. Immunol. 10:1998;237-248.
4. Wu L., Gerard N. P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A. A., Desjardin E., Newman W., Gerard C., Sodroski J. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature. 384:1996;179-183.
5. Martin K. A., Wyatt R., Farzan M., Choe H., Marcon L., Desjardins E., Robinson J., Sodroski J., Gerard C., Gerard N. P. CD4-independent binding of SIV gp120 to rhesus CCR5. Science. 278:1997;1470-1473.
6. Farzan M., Choe H., Vaca L., Martin K., Sun Y., Desjardins E., Ruffing N., Wu L., Wyatt R., Gerard N., Gerard C., Sodroski J. A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J. Virol. 72:1998;1160-1164.
7. Dragic T., Trkola A., Lin S. W., Nagashima K. A., Kajumo F., Zhao L., Olson W. C., Wu L., Mackay C. R., Allaway G. P., Sakmar T. S., Moore J. P., Maddon P. J. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol. 72:1998;279-285.
8. Rabut G. E. E., Konner J. A., Kajumo F., Moore J. P., Dragic T. Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1. J. Virol. 72:1998;3464-3468.
9. Siciliano S. J., Kuhmann S. E., Weng Y., Madani N., Springer M. S., Lineberger J. E., Danzeisen R., Miller M. D., Kavanaugh M. P., DeMartino J. A., Kabat D. A critical site in the core of the CCR5 chemokine receptor required for binding and infectivity of human immunodeficiency virus type 1. J. Biol. Chem. 274:1999;1905-1913.
10. Samson M., LaRosa G., Libert F., Paindavoine P., Detheux M., Vassart G., Parmentier M. The second extracellular loop of CCR5 is the major determinant of ligand specificity. J. Biol. Chem. 272:1997;24934-24941.
11. Doranz B. J., Orsini M. J., Turner J. D., Hoffman T. L., Berson J. F., Hoxie J. A., Peiper S. C., Brass L. F., Doms R. W. Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol. 73:1999;2752-2761.
12. Rizzuto C. D., Wyatt R., Hernández-Ramos N., Sun Y., Kwong P. D., Hendrickson W. A., Sodroski J. A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science. 280:1998;1949-1953.
13. LaCasse R. A., Follis K. E., Trahey M., Scarborough J. D., Littman D. R., Nunberg J. H. Fusion-competent vaccines: Broad neutralization of primary isolates of HIV. Science. 283:1999;357-362.
14. Lapham C. K., Ouyang J., Chandrasekhar B., Nguyen N. Y., Dimitrov D. S., Golding H. Evidence for cell-surface association between Fusin and the CD4-gp120 complex in human cell lines. Science. 274:1996;602-605.
15. Doranz, B. J, Baik, S. W, and, Doms, R. W. 1999, Use of a gp120 binding assay to dissect the requirements and kinetics of HIV fusion events. Submitted for publication.
16. Rucker J., Samson M., Doranz B. J., Libert F., Berson J. F., Yi Y., Smyth R. J., Collman R. G., Broder C. C., Vassart G., Doms R. W., Parmentier M. Regions in β-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity. Cell. 87:1996;437-446.
17. Doranz B. J., Lu Z., Rucker J., Zhang T., Sharron M., Cen Y., Wang Z., Guo H., Du J., Accavitti M. A., Doms R. W., Peiper S. C. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1. J. Virol. 71:1997;6305-6314.
18. Lee B., Sharron M., Blanpain C., Doranz B. J., Vakili J., Setoh P., Berg E., Liu G., Guy H. R., Durell S. R., Parmentier M., Chang C. N., Price K., Tsang M., Doms R. W. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J. Biol. Chem. 274:1999;9617-9626.
19. Edinger A. L., Amedee A., Miller K., Doranz B. J., Endres M., Sharron M., Samson M., Lu Z., Clements J. E., Murphey-Corb M., Peiper S. C., Parmentier M., Broder C. C., Doms R. W. Differential utilization of CCR5 by macrophage and T-cell tropic SIV strains. Proc. Natl. Acad. Sci. USA. 94:1997;4005-4010.
20. Limbird L. E. Cell Surface Receptors. 1996;Kluwer Academic, Norwell.
21. Platt E. J., Wehrly K., Kuhmann S. E., Chesebro B., Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:1998;2855-2864.
22. Doranz B. J., Grovit-Ferbas K., Sharron M. P., Mao S., Goetz M. B., Daar E. S., Doms R. W., O'Brien W. A. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J. Exp. Med. 186:1997;1395-1400.